Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes.

about

Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes.

Item

http://www.wikidata.org/entity/Q51783552

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Low-dose post-transplant cyclo ...... identical transplant outcomes.

@en

Low-dose post-transplant cyclo ...... identical transplant outcomes.

@nl

type

Item

label

Low-dose post-transplant cyclo ...... identical transplant outcomes.

@en

Low-dose post-transplant cyclo ...... identical transplant outcomes.

@nl

prefLabel

Low-dose post-transplant cyclo ...... identical transplant outcomes.

@en

Low-dose post-transplant cyclo ...... identical transplant outcomes.

@nl

P1476

Low-dose post-transplant cyclo ...... oidentical transplant outcomes

@en

P2093

Chen-Hua Yan

http://www.w3.org/2001/XMLSchema#string

Kai-Yan Liu

http://www.w3.org/2001/XMLSchema#string

Lan-Ping Xu

http://www.w3.org/2001/XMLSchema#string

Lu Chen

http://www.w3.org/2001/XMLSchema#string

Xiao-Hui Zhang

http://www.w3.org/2001/XMLSchema#string

Xiao-Jun Huang

http://www.w3.org/2001/XMLSchema#string

Yu Wang

http://www.w3.org/2001/XMLSchema#string

Zhi-Lei Bian

http://www.w3.org/2001/XMLSchema#string

P2860

Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide

Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation.

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.

Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant.

Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.

P304

e1356152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1356152

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yingjun Chang

P577

2017-09-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29147612

http://www.w3.org/2001/XMLSchema#string

P932

5674947

http://www.w3.org/2001/XMLSchema#string